Annovis Bio, Inc.
ANVSNYSE
Healthcare
Biotechnology
$2.50
+0.22(9.6%)
52W $1.22 – $5.10
Quick:
8-K
Mar 25, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 13, 2026 (3 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 12, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 28, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 28, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 14, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 29, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 15, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Jun 23, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 20, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 13, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 13, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
May 12, 2025 (10 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Mar 27, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 21, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 21, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction